| Modern subunit vaccines: development, components, and research opportunities PM Moyle, I Toth ChemMedChem 8 (3), 360-376, 2013 | 305 | 2013 |
| Self-adjuvanting lipopeptide vaccines PM Moyle, I Toth Current medicinal chemistry 15 (5), 506-516, 2008 | 155 | 2008 |
| Mucosal immunisation: adjuvants and delivery systems PM Moyle, RP McGeary, JT Blanchfield, I Toth Current drug delivery 1 (4), 385-396, 2004 | 94 | 2004 |
| Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines PM Moyle Biotechnology advances 35 (3), 375-389, 2017 | 66 | 2017 |
| Structure–activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates ABM Abdel-Aal, MR Batzloff, Y Fujita, N Barozzi, A Faria, P Simerska, ... Journal of medicinal chemistry 51 (1), 167-172, 2008 | 62 | 2008 |
| Method for the synthesis of mono-ADP-ribose conjugated peptides PM Moyle, TW Muir Journal of the American Chemical Society 132 (45), 15878-15880, 2010 | 56 | 2010 |
| Modern lipid‐, carbohydrate‐, and peptide‐based delivery systems for peptide, vaccine, and gene products P Simerska, PM Moyle, I Toth Medicinal research reviews 31 (4), 520-547, 2011 | 48 | 2011 |
| Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines PM Moyle, C Olive, MF Ho, M Pandey, J Dyer, A Suhrbier, Y Fujita, I Toth Journal of medicinal chemistry 50 (19), 4721-4727, 2007 | 48 | 2007 |
| Polymer–peptide hybrids as a highly immunogenic single-dose nanovaccine AAH Ahmad Fuaad, Z Jia, M Zaman, J Hartas, ZM Ziora, IC Lin, PM Moyle, ... Nanomedicine 9 (1), 35-43, 2014 | 46 | 2014 |
| Oral vaccine delivery-new strategies and technologies P Simerska, PM Moyle, C Olive, I Toth Current drug delivery 6 (4), 347-358, 2009 | 44 | 2009 |
| Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation PM Moyle, C Olive, MF Ho, MF Good, I Toth Journal of Medicinal Chemistry 49 (21), 6364-6370, 2006 | 42 | 2006 |
| Glucagon-like peptide-1 (GLP-1)-based therapeutics: current status and future opportunities beyond type 2 diabetes JY Cheang, PM Moyle ChemMedChem 13 (7), 662-671, 2018 | 41 | 2018 |
| Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccines PM Moyle, W Dai, Y Zhang, MR Batzloff, MF Good, I Toth Bioconjugate chemistry 25 (5), 965-978, 2014 | 39 | 2014 |
| Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines P Simerska, ABM Abdel-Aal, Y Fujita, PM Moyle, RP McGeary, ... Journal of medicinal chemistry 51 (5), 1447-1452, 2008 | 37 | 2008 |
| Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity M Zaman, S Chandrudu, AK Giddam, J Reiman, M Skwarczynski, ... Nanomedicine 9 (17), 2613-2624, 2014 | 36 | 2014 |
| Bioconjugation approaches to producing subunit vaccines composed of protein or peptide antigens and covalently attached toll-like receptor ligands Z Xu, PM Moyle Bioconjugate chemistry 29 (3), 572-586, 2017 | 33 | 2017 |
| Method for the synthesis of highly pure vaccines using the lipid core peptide system PM Moyle, C Olive, MF Good, I Toth Journal of peptide science: an official publication of the European Peptide …, 2006 | 31 | 2006 |
| Endosome escape strategies for improving the efficacy of oligonucleotide delivery systems Y Wan, PM Moyle, I Toth Current medicinal chemistry 22 (29), 3326-3346, 2015 | 30 | 2015 |
| Differing efficacies of lead group A streptococcal vaccine candidates and full-length M protein in cutaneous and invasive disease models T Rivera-Hernandez, M Pandey, A Henningham, J Cole, B Choudhury, ... MBio 7 (3), e00618-16, 2016 | 29 | 2016 |
| An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development system PM Moyle, J Hartas, A Henningham, MR Batzloff, MF Good, I Toth Nanomedicine: Nanotechnology, Biology and Medicine 9 (7), 935-944, 2013 | 29 | 2013 |
Istvan TothChair in Biological ChemistryVerified email at uq.edu.au
